Evaluation of the Alcohol Elimination Effect of TCI711 Probiotic (Bacillus Coagulans) on Adult Individuals

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04457661

Acronym

TCI711

Enrollment

Registered

2020-07-07

Start date

2020-07-13

Completion date

2020-12-31

Last updated

2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breath Alcohol Level

Brief summary

Investigating the possibility of using Bacillus coagulans TCI711 to improve the efficiency of alcohol removal in adult individuals.

Interventions

DIETARY_SUPPLEMENTBacillus coagulans TCI711

Using Bacillus coagulans TCI711 for one month and implementing alcohol testing at weeks 0, 1, and 4.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy volunteers aged between 20 to 60. * Systolic pressure below 140 * Score of C-CAGE Questionnaire below 8 (male)/6 (female) * Prohibiting other supplements before 2 weeks of the study and during the study * Prohibiting alcohol drinks before 24 hours of the study * Prohibiting caffeine drinks before 12 hours of the study

Exclusion criteria

* Alcohol or drug allergy * Liver, kidney, cardiovascular, or chronic diseases * Other severe disorders * Hypertension * Pregnancy or lactation * Already involved in clinical testing * Other supplements

Design outcomes

Primary

Measure	Time frame	Description
Breath Alcohol Level	5 minutes after drinking a certain volume of whisky	A breathalyzer will be used for estimating blood alcohol content (BAC) from a breath sample.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026